VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $765,000 | +16.4% | 31,150 | -4.5% | 0.30% | +24.2% |
| Q2 2016 | $657,000 | -19.1% | 32,615 | +5.6% | 0.24% | -16.7% |
| Q1 2016 | $812,000 | -69.4% | 30,890 | +18.2% | 0.29% | -65.3% |
| Q4 2015 | $2,656,000 | -6.2% | 26,130 | +64.7% | 0.83% | -12.3% |
| Q3 2015 | $2,831,000 | -23.1% | 15,870 | -4.2% | 0.95% | -19.9% |
| Q2 2015 | $3,681,000 | +0.5% | 16,570 | -10.1% | 1.18% | +7.5% |
| Q1 2015 | $3,661,000 | +22.1% | 18,430 | -12.0% | 1.10% | +24.2% |
| Q4 2014 | $2,999,000 | +16.7% | 20,955 | +7.0% | 0.88% | +16.4% |
| Q3 2014 | $2,569,000 | +6.2% | 19,580 | +2.1% | 0.76% | -4.8% |
| Q2 2014 | $2,419,000 | -2.1% | 19,180 | +2.4% | 0.80% | -8.5% |
| Q1 2014 | $2,470,000 | +22.8% | 18,735 | +9.4% | 0.87% | +25.1% |
| Q4 2013 | $2,011,000 | – | 17,125 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |